Regeneron Pharmaceuticals, Inc.
REGNHealthcare · Stock · quarterly payer
Forward Yield
0.56%
Annual Dividend
$3.76
Payout Ratio
9%
5-Yr Growth
—
Ex-Date
May 20, 2026
Frequency
Quarterly
Summary
As of July 2026, Regeneron Pharmaceuticals, Inc. (REGN) yields 0.56% ($3.76 per share annually), with a blended fair-value estimate of $1,395.33 — +106% upside, so it screens as undervalued.
Is REGN a good dividend stock?
MixedRegeneron Pharmaceuticals, Inc. (REGN) pays a quarterly dividend yielding 0.56% ($3.76/yr), with 0 years of growth. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.
Advantages
- Never cut its dividend on record
- Comfortable payout ratio (9%)
Risks
- Single-stock concentration risk — diversify
Key Data
- Dividend Yield
- 0.56%
- Payout Ratio
- 9%
- Annual Dividend
- $3.76
- 5-Yr Avg Growth
- —
- Ex-Dividend Date
- May 20, 2026
- Years of Growth
- 0
- Frequency
- quarterly
- Beta
- 0.24
- Market Cap
- $70.5B
- P/E Ratio
- 16.5
- 5-Yr Total Return
- 0%
- 52-Week Range
- $541.00 – $821.11
- Dividend Safety
- —
- Ever Cut?
- No
Frequently Asked Questions
REGN Price — Last 12 Months
Daily close
Price Return
1 Year
+17%
3 Years
-18%
5 Years
+0%
52-Week Range
$541.00 – $821.11
Price change over each period (excludes dividends). Past performance doesn't guarantee future results.
What is REGN worth?
Undervaluedlow confidenceOur blended fair-value estimate for Regeneron Pharmaceuticals, Inc. is $1,395.33 per share, versus a market price of $676.69. That implies 106% of upside — a margin of safety of about 52%.
Fair Value
$1,395.33
Current Price
$676.69
Upside
+106%
Margin of Safety
52%
How we get there
Discounted cash flow
Discounts projected free cash flow back to today.
Earnings multiple (Graham)
Graham's earnings-multiple formula, anchored to bond yields.
At today's price, the market is pricing in about -4.2% annual free-cash-flow growth. We model 13.7% — below our estimate, leaving room for upside if the business executes.
Assumptions: 7.0% discount rate (CAPM), 13.7% stage-1 growth, 2.5% terminal growth, $40.94 EPS, $3.76 annual dividend. Updated weekly.
Fair-value estimates are model output for educational purposes only — not investment advice or a price target.
Dividend History
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| May 20, 2026 | — | $0.9400 | regular |
| Feb 20, 2026 | — | $0.9400 | regular |
| Nov 20, 2025 | — | $0.8800 | regular |
| Aug 18, 2025 | — | $0.8800 | regular |
| May 20, 2025 | — | $0.8800 | regular |
| Feb 20, 2025 | — | $0.8800 | regular |
Income Calculator
At $3.76 / yr per share
